GL1X · GenesisL1 explorer

Research workbench

Crystal structure of de novo designed MID1-zinc H12E mutant

Analyse Crystal structure of de novo designed MID1-zinc H12E mutant in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3V1E
Type
protein
Length
86 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Computational design, MID1-zinc H12E mutant
Ligands
ZN
Pockets
1 · best druggability 0.58

Structure

x-ray diffraction · 2 distinct chains · 78% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AComputational design, MID1-zinc H12E mutantprotein4386% helix, 0% strand—
BComputational design, MID1-zinc H12E mutantprotein4370% helix, 0% strand—

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11930.580.8122empty

Interfaces

1 interface between chains.

  • A–B · 491 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 3V1E · Crystal structure of de novo designed MID1-zinc H12E mutant · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.